GH Blend (4X) (GHRP-2 + Tesamorelin + MGF + Ipamorelin)

Early human Growth Hormone In 1 protocol 3 sources

GH Blend (4X) is a synergistic combination of four peptides designed to maximize growth hormone release and tissue repair. It combines two GH secretagogues (GHRP-2 and Ipamorelin) with a growth hormone-releasing hormone analogue (Tesamorelin) to stimulate the pituitary gland, while Mechano Growth Factor (MGF) promotes localized muscle repair and cellular growth.

01Dosing reference

Amount

200-500 mcg/day (total blend)

Frequency

1-2x daily (often pre-workout or before bed)

Cycle

8-12 weeks on, 4 weeks off

Reference figures, not a recommendationThese values reflect amounts described in the literature and vendor documentation this database indexes. Use the reconstitution calculator to convert them into syringe units.

02Mechanism of action

Pituitary Stimulation

Tesamorelin binds to GHRH receptors, while GHRP-2 and Ipamorelin bind to ghrelin/GHS receptors on the pituitary gland.

Synergistic GH Release

The dual activation of GHRH and GHS receptors results in a synergistic, pulsatile release of endogenous growth hormone.

Tissue Repair and Hypertrophy

MGF acts locally on muscle tissue to activate satellite cells, promoting muscle repair and growth alongside the systemic effects of elevated GH and IGF-1.

03Human evidence

Tesamorelin significantly reduces visceral adipose tissue in patients with HIV-associated lipodystrophy.

FDA-approved clinical trials demonstrating targeted fat reduction without significant alterations to glucose metabolism.

Ipamorelin and GHRP-2 effectively stimulate GH release in healthy adults with minimal impact on cortisol and prolactin compared to older secretagogues.

Phase 1 and 2 clinical trials evaluating safety and efficacy of GH secretagogues.

04Preclinical evidence

MGF administration in animal models significantly enhances muscle hypertrophy and accelerates repair following mechanical damage.

Rodent models of muscle injury and mechanical overload.

Co-administration of GHRH analogues and GHRPs produces a synergistic release of GH that is greater than the sum of their individual effects.

In vivo animal studies measuring pituitary hormone secretion.

05What is known vs. unknown

Reasonably established

Combines GHRH (Tesamorelin) and GHRPs (Ipamorelin, GHRP-2) for synergistic growth hormone secretion.
Includes MGF to specifically target muscle tissue repair and satellite cell activation.
Tesamorelin is known for its ability to reduce visceral fat.
Ipamorelin is highly selective, causing minimal spikes in cortisol or prolactin.
GHRP-2 is a potent GH secretagogue but may slightly increase appetite and cortisol compared to Ipamorelin.

Unknowns & limits

The exact synergistic effects and safety profile of combining all four peptides simultaneously have not been evaluated in formal clinical trials.
Long-term effects of continuous, multi-pathway GH axis stimulation remain unknown.
MGF's systemic vs. localized effects when administered subcutaneously in a blend are not fully understood.

06Safety & regulatory context

Regulatory statusWhile Tesamorelin is FDA-approved for a specific indication (HIV-associated lipodystrophy), the other components (GHRP-2, Ipamorelin, MGF) are primarily research chemicals and not approved for human use. Potential side effects of this blend may include injection site reactions, water retention, increased appetite (due to GHRP-2), joint pain, and altered insulin sensitivity. The combination of multiple GH-stimulating agents increases the risk of overstimulating the pituitary gland. This blend is strictly for research purposes and is not regulated or approved by the FDA for general medical use.

07Compared with CJC-1295 / Ipamorelin Blend

GH Blend (4X) (GHRP-2 + Tesamorelin + MGF + Ipamorelin) vs. CJC-1295 / Ipamorelin Blend

Key difference

The 4X blend includes MGF for direct muscle repair and uses Tesamorelin (a potent GHRH) along with two GHRPs, making it a more aggressive, multi-pathway approach compared to the standard CJC/Ipamorelin duo.

When researchers discuss each

CJC/Ipamorelin is often discussed as a baseline, well-tolerated anti-aging and recovery protocol, whereas the 4X blend is typically researched in contexts requiring maximal tissue repair, severe muscle wasting, or advanced body composition changes.

08Appears in protocols

🔬 GH Blend (4X) Multi-Peptide Protocol

30 units (as directed per vial)5 nights per week

09Glossary

Growth Hormone Secretagogue (GHS)

A substance that signals the pituitary gland to secrete growth hormone.

Mechano Growth Factor (MGF)

A splice variant of IGF-1 that is naturally produced in muscle tissue in response to mechanical stress or damage, promoting repair.

Synergistic Effect

An interaction where the combined effect of multiple substances is greater than the sum of their individual effects.

10Knowledge check

Q1Why are GHRH analogues (like Tesamorelin) and GHRPs (like Ipamorelin) often combined in research?

Q2What is the primary role of MGF in this blend?

Q3Which documented limitation about the GH Blend (4X) is explicitly stated in the dossier?

Q4According to the dossier, how does the GH Blend (4X) conceptually differ from a CJC-1295/Ipamorelin blend?

Q5Which regulatory or safety point about the blend's components is stated in the dossier?

11Sources

More in Growth Hormone

See all

Sermorelin

Growth Hormone

FDA-approved context

Sermorelin is a synthetic peptide consisting of the first 29 amino acids of naturally occurring growth hormone-releasing hormone (GHRH). It stimulates the pituitary gland to naturally produce and release human growth hormone (hGH), making it a subject of research for age-related growth hormone decline, body composition, and vitality.

200-500 mcg/day

Tesamorelin

Growth Hormone

FDA-approved context

Tesamorelin is a synthetic analogue of growth hormone-releasing hormone (GHRH) that stimulates the pituitary gland to secrete growth hormone. It is FDA-approved for reducing excess visceral abdominal fat in HIV-infected patients with lipodystrophy and is being researched for potential cognitive benefits.

2 mg/day

Hexarelin

Growth Hormone

Human clinical

Hexarelin is a potent, synthetic hexapeptide and growth hormone secretagogue (GHS) that stimulates the release of growth hormone. Research indicates it is one of the strongest GH-releasing peptides available, offering potential benefits for muscle growth, fat loss, and cardiovascular health without significantly increasing appetite.

100-200 mcg per dose

Research and educational use onlyNothing on this site is medical advice, a prescription, or a recommendation for human use. Compounds documented here are research chemicals. Consult a qualified clinician before making any health decision.